Tsuyoshi Ohta

Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models

Seiji Mabuchi, Masahide Ohmichi, Yukihiro Nishio et al. · Journal of Biological Chemistry · 2004 · 212 citations · Full text

Medicine, Oncology, Pharmacology +14

Inhibition of Inhibitor of Nuclear Factor-κB Phosphorylation Increases the Efficacy of Paclitaxel in <b> <i>in Vitro</i> </b> and <b> <i>in Vivo</i> </b> Ovarian Cancer Models

Seiji Mabuchi, Masahide Ohmichi, Yukihiro Nishio et al. · Clinical Cancer Research · 2004 · 114 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of Phosphatidylinositol 3-Kinase Increases Efficacy of Cisplatin in in Vivo Ovarian Cancer Models

Tsuyoshi Ohta, Masahide Ohmichi, Tadashi Hayasaka et al. · Endocrinology · 2006 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

Fasudil inhibits vascular endothelial growth factor–induced angiogenesis<i>in vitro</i>and<i>in vivo</i>

Limei Yin, Ken‐ichirou Morishige, Toshifumi Takahashi et al. · Molecular Cancer Therapeutics · 2007 · 84 citations · Full text

Life Sciences, Cell Biology, Pharmacology +15

Annual report of the <scp>Committee on Gynecologic Oncology</scp>, the <scp>Japan Society of Obstetrics and Gynecology</scp>: Annual patient report for 2017 and annual treatment report for 2012

Satoru Nagase, Tsuyoshi Ohta, Fumiaki Takahashi et al. · Journal of obstetrics and gynaecology research · 2021 · 81 citations

Medicine, Gynecology, Oncology +12